Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR goggles may ease anxiety and improve sleep for COPD patients in the ICU

NCT ID NCT07475650

Symptom relief Sponsor: TC Erciyes University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether using virtual reality (VR) glasses for 30 minutes each evening could improve sleep quality, reduce anxiety, and stabilize vital signs in intensive care patients with COPD. Fifty patients were split into two groups: one received VR sessions for a week, the other received standard care. Sleep and anxiety were measured using standard scales, and vital signs were tracked before and after each session.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual reality glasses
What this could lead to
If it works, this could offer a simple, drug-free way to help ICU patients with COPD sleep better and feel less anxious during their hospital stay.
What could go wrong
This is a small, completed study with only 50 participants. The results may not apply to all COPD patients or other hospital settings. The effect may be modest and not a substitute for medical treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Nov 2022

Finished

Feb 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Conscious and oriented, able to cooperate * Aged 18 years and older * Diagnosed with COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2022 criteria (Stage II, Stage III, or Stage IV) * Hospitalized in the intensive care unit for at least 24 hours in order to evaluate sleep problems * No history of psychiatric disorders or cognitive impairment * No complaints such as migraine, dizziness, active nausea, vomiting, or headache * No visual, hearing, or cognitive impairments Exclusion Criteria: * Patients with a Richmond Agitation-Sedation Scale (RASS) score less than -1 * Patients receiving invasive or non-invasive mechanical ventilation Discontinuation Criteria: * Experience problems with the virtual reality headset or report feeling unwell during the intervention * Initiation of any medication that affects sleep * Requirement for intubation * Initiation of medication for anxiety or sedation * Need for Continuous Positive Airway Pressure (CPAP) or Bilevel Positive Airway Pressure (BPAP) during the virtual reality intervention

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder chronic obstructive pulmonary disease COPD, severe early onset insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety COPD Sleep quality of icu patients

Contacts and locations

Locations

  • Faculty of Health Sciences Erciyes University

    Kayseri, Melikgazi, 38260, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.